Abstract
Eleven children with acute lymphoblastic leukemia and chronic liver disease, who had negative reactions for hepatitis B virus markers in the liver, were studied at the time of therapy withdrawal for an antigen-antibody system linked to non-A, non-B (NANB) hepatitis infection. By immunofluorescence, six of the 11 children had a positive reaction for the NANB antigen in the liver, and five of these six children also had a positive reaction for the NANB antibody in serum. Histologic lesions were more severe in patients with the NANB antigen in the liver compared with those with a negative reaction.
Citations
Jun 1, 1993·European Journal of Pediatrics·F M FinkH Gadner
Jan 9, 2003·Medical and Pediatric Oncology·Päivi HalonenAnne Mäkipernaa
Jan 1, 1985·Medical and Pediatric Oncology·A LocasciulliP Paolucci
Jul 31, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sandra L WatkinsUNKNOWN Southwest Pediatric Nephrology Study Group
Jun 1, 1992·Journal of Medical Virology·A KumarR Mehrotra
Sep 1, 1991·Journal of Medical Virology·S C HsuC Y Lee
Aug 1, 1993·Journal of Medical Virology·E KolhoT Krusius
Oct 15, 1988·Cancer·M L Hetherington, G R Buchanan
Sep 15, 1983·Cancer·A LocasciulliG Masera
Jan 1, 1990·Leukemia & Lymphoma·A LocasciulliA Alberti
Apr 1, 1995·Leukemia & Lymphoma·A Locasciulli, A Alberti
May 1, 1997·JPEN. Journal of Parenteral and Enteral Nutrition·S KleinP Twomey
Oct 1, 1995·Acta Paediatrica Japonica; Overseas Edition·H NoguchiG Takada